Preliminary results of immune modulating antibody MDV9300 (pidilizumab) treatment in children with diffuse intrinsic pontine glioma
Crossref DOI link: https://doi.org/10.1007/s11060-017-2643-1
Published Online: 2017-11-15
Published Print: 2018-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fried, Iris
Lossos, Alex
Ben Ami, Tal
Dvir, Rina
Toledano, Helen
Ben Arush, Myriam Weil
Postovski, Sergei
Abu Kuidar, Abed
Yalon, Michal
Weintraub, Michael
Benifla, Mony
License valid from 2017-11-15